SARAH HECKMAN: Open Payments
NPI 1235525122 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,066 in 55 payments from 17 companies in 2025. Trend: 2023 $123 · 2024 $622 · 2025 $1,066
Food & beverage: $1,066
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $174 |
| PFIZER INC. | 11 | $160 |
| Novo Nordisk Inc | 7 | $140 |
| Medtronic, Inc. | 2 | $110 |
| Dexcom, Inc. | 3 | $79 |
| Lilly USA, LLC | 3 | $70 |
| Amgen Inc. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: INTELLIS ADAPTIVESTIM, NURTEC ODT, VRAYLAR, Dexcom G6 Transmitter, JARDIANCE, REXULTI, Wegovy, QULIPTA.
Industry payments across IN — which companies pay providers there.
